Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Hypertension: β testing
Michael Kotlikoff, Ian Hall
Michael Kotlikoff, Ian Hall
Published September 1, 2003
Citation Information: J Clin Invest. 2003;112(5):654-656. https://doi.org/10.1172/JCI19580.
View: Text | PDF
Commentary

Hypertension: β testing

  • Text
  • PDF
Abstract

A new study demonstrates that angiotensin-induced hypertension results in a marked decrease in expression of the β subunit of the BK channel, suggesting a role for this critical subunit in the regulation of vascular tone.

Authors

Michael Kotlikoff, Ian Hall

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
The β subunit tunes the coupling of BK channels to RyR Ca2+ release. Gat...
The β subunit tunes the coupling of BK channels to RyR Ca2+ release. Gating of ryanodine receptors (RyR) in the sarcoplasmic reticulum (SR) results in brief, localized increases in Ca2+, termed Ca2+ sparks (red stars). These Ca2+ sparks activate a few BK channels in the sarcolemma (SL), resulting in spontaneous transient outward currents, or STOCs (currents shown above), which hyperpolarize and relax the myocyte, leading to vasodilation. The β subunit of the BK channel plays a critical role in regulating the sensitivity of the BK channel complex to Ca2+ ions, and Amberg et al. (7) now establish a link between hypertension, produced by a chronic infusion of angiotensin (AngII), and this channel subunit. Equivalent Ca2+ sparks produce smaller and less frequent STOCs in hypertensive mice, and this appears to result from a decrease in expression of the β1 subunit following angiotensin infusion. The results focus attention on transcriptional regulation of the β subunit and how this may be affected by activation of AT1 receptors.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts